Quarterly report pursuant to Section 13 or 15(d)

NET OPERATING REVENUES (Details)

v3.22.1
NET OPERATING REVENUES (Details) - USD ($)
$ in Millions
 3 Months Ended
Apr. 01, 2022
Apr. 02, 2021
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues $ 10,491 $ 9,020
Concentrate Revenue    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 5,724 4,982
Finished product operations    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 4,767 4,038
UNITED STATES    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 3,523 2,893
UNITED STATES | Concentrate Revenue    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 1,641 1,410
UNITED STATES | Finished product operations    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 1,882 1,483
International [Member]    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 6,968 6,127
International [Member] | Concentrate Revenue    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues 4,083 3,572
International [Member] | Finished product operations    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Net Operating Revenues $ 2,885 $ 2,555